| Global Phylogeny of Mycobacterium tuberculosis Based on Single Nucleotide Polymorphism (SNP) Analysis: Insights into Tuberculosis Evolution, Phylogenetic … I Filliol, AS Motiwala, M Cavatore, W Qi, MH Hazbón, ... Journal of bacteriology 188 (2), 759-772, 2006 | 560 | 2006 |
| Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020 GB Migliori, PM Thong, O Akkerman, JW Alffenaar, F Álvarez-Navascués, ... Emerging infectious diseases 26 (11), 2709, 2020 | 225 | 2020 |
| Is It Ever Safe To Stop Azole Therapy for Coccidioides immitis Meningitis? DH Dewsnup, JN Galgiani, JR Graybill, M Diaz, A Rendon, GA Cloud, ... Annals of internal medicine 124 (3), 305-310, 1996 | 222 | 1996 |
| MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network GB Migliori, S Tiberi, A Zumla, E Petersen, JM Chakaya, C Wejse, ... International Journal of Infectious Diseases 92, S15-S25, 2020 | 221 | 2020 |
| Isavuconazole treatment of cryptococcosis and dimorphic mycoses GR Thompson, A Rendon, R Ribeiro dos Santos, F Queiroz-Telles, ... Reviews of Infectious Diseases 63 (3), 356-362, 2016 | 187 | 2016 |
| Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report S Borisov, E Danila, A Maryandyshev, M Dalcolmo, S Miliauskas, L Kuksa, ... European Respiratory Journal 54 (6), 2019 | 186 | 2019 |
| Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico SV Ramaswamy, SJ Dou, A Rendon, Z Yang, MD Cave, EA Graviss Journal of medical microbiology 53 (2), 107-113, 2004 | 164 | 2004 |
| Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study GB Migliori, PM Thong, JW Alffenaar, J Denholm, M Tadolini, F Alyaquobi, ... European Respiratory Journal 58 (5), 2021 | 146 | 2021 |
| Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis A Catanzaro, GA Cloud, DA Stevens, BE Levine, PL Williams, ... Clinical infectious diseases 45 (5), 562-568, 2007 | 129 | 2007 |
| Posaconazole therapy for chronic refractory coccidioidomycosis DA Stevens, A Rendon, V Gaona-Flores, A Catanzaro, GM Anstead, ... Chest 132 (3), 952-958, 2007 | 124 | 2007 |
| Tuberculosis and COVID-19 co-infection: description of the global cohort TB/COVID-19 Global Study Group European Respiratory Journal 59 (3), 2022 | 123 | 2022 |
| Tuberculosis elimination: where are we now? A Matteelli, A Rendon, S Tiberi, S Al-Abri, C Voniatis, ACC Carvalho, ... European Respiratory Review 27 (148), 2018 | 118 | 2018 |
| Coccidioidomycosis O Welsh, L Vera-Cabrera, A Rendon, G Gonzalez, A Bonifaz Clinics in dermatology 30 (6), 573-591, 2012 | 101 | 2012 |
| In Vitro Activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis L Vera-Cabrera, E Gonzalez, A Rendon, J Ocampo-Candiani, O Welsh, ... Antimicrobial agents and chemotherapy 50 (9), 3170-3172, 2006 | 98 | 2006 |
| The cursed duet today: Tuberculosis and HIV-coinfection S Tiberi, ACC Carvalho, G Sulis, D Vaghela, A Rendon, FCQ Mello, ... La Presse Médicale 46 (2), e23-e39, 2017 | 95 | 2017 |
| CD14 C (-159) T polymorphism is a risk factor for development of pulmonary tuberculosis AG Rosas-Taraco, A Revol, MC Salinas-Carmona, A Rendon, ... The Journal of infectious diseases 196 (11), 1698-1706, 2007 | 91 | 2007 |
| Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis? M Muñoz-Torrico, A Rendon, R Centis, L D'Ambrosio, Z Fuentes, ... Jornal Brasileiro de Pneumologia 42, 374-385, 2016 | 89 | 2016 |
| coccidioidomycosis in Latin America R Laniado-Laborín, EG Arathoon, C Canteros, R Muñiz-Salazar, ... Medical mycology 57 (Supplement_1), S46-S55, 2019 | 81 | 2019 |
| Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review L D’Ambrosio, R Centis, S Tiberi, M Tadolini, M Dalcolmo, A Rendon, ... Journal of thoracic disease 9 (7), 2093, 2017 | 78 | 2017 |
| Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis RM Narvaez-Rivera, A Rendon, MC Salinas-Carmona, AG Rosas-Taraco BMC infectious diseases 12, 1-8, 2012 | 75 | 2012 |
